Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | MOGAT2 | Q3SYC2 | 3/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | PPARG | P37231 | 3/20 | 0.31 |
| ▸ | PPARA | Q07869 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20407559 | 0.96 | FFAR4 (0.31) | FFAR4PPARGPPARA | |
| SCHEMBL20322748 | 0.94 | MOGAT2 (0.31) | FFAR4MOGAT2CYP2C9 | |
| SCHEMBL20313586 | 0.92 | PPARG (0.33) | FFAR4CYP2C9PPARGPPARA | |
| SCHEMBL20322670 | 0.89 | FFAR4 (0.33) | FFAR4MOGAT2CYP2C9 | |
| SCHEMBL19853845 | 0.89 | FFAR4 (0.33) | FFAR4MOGAT2CYP2C9 | |
| SCHEMBL20322671 | 0.89 | ESR2 (0.32) | FFAR4 | |
| SCHEMBL19855089 | 0.89 | ESR2 (0.32) | FFAR4 | |
| SCHEMBL19855093 | 0.88 | CYP3A4 (0.31) | FFAR4CYP2C9 | |
| SCHEMBL19853851 | 0.87 | FFAR4 (0.33) | FFAR4CYP2C9PPARGPPARA | |
| SCHEMBL19853861 | 0.87 | PTPN11 (0.33) | FFAR4CYP2C9PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214615-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT | JNC CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| US-20180179443-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180179443-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | C1S, CCND1, C5 | FFAR4 1865/4885MOGAT2 3146/4885CYP2C9 3375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.